Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank63
Studio
Year-over-Year Change

Return on equity

Latest
19.93%
↑ 283% vs avg
Percentile
P63
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-10.88%
Historical baseline
PeriodValueYoY Change
202519.93%+123.8%
2024-83.66%-18.5%
2023-70.62%+10.4%
2022-78.80%-22.9%
2021-64.11%-193.4%
2020-21.85%-129.2%
201974.77%+30.1%
201857.46%-16.7%
201768.94%-